My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
September 2014
Policy and Advocacy
Federal Funding Process Stalled Just Weeks Ahead of New Fiscal Year
Congress has yet to approve bills to fund domestic and global health programs beyond the start of the new fiscal year, October 1.  Policy differences between leaders in both the House and Senate have largely hobbled the annual appropriations process.  

The current standoff comes just as promising spending levels were proposed for some ID and HIV programs. After much advocacy by IDSA, HIVMA and other health groups, important funding increases were proposed for the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), Health Resources and Services Administration (HRSA), and the United States Agency for International Development (USAID).

For ID, a Senate subcommittee identified $30 million in new funding for the CDC to increase its efforts to address antimicrobial resistance, provided an increase to $32 million for the National Healthcare Safety Network (NHSN), continued support at $30 million for Advance Molecular Detection (AMD), sustained funding at $611 million for the Section 317 immunization program, continued support for the Biomedical Advanced Research and Development Authority (BARDA), and provided a marginal increase to the National Institute of Allergy and Infectious Diseases (NIAID) to $4.452 million.

In HIV, flat funding was provided for most HIV/AIDS-related programs with the exception of small increases for the AIDS Drug Assistance Program ($5 million). HIVMA was able to help secure favorable report language supporting the role of the NIH’s Office of AIDS Research and the subcommittee report also includes helpful language exempting scientific meetings from restrictions that have been placed on federal participation in conferences.  In addition, the bill contains report language that would lift the ban on the use of federal funding to support syringe access programs. These developments would be erased if Congress fails to proactively move the FY2015 funding bills and reverts to the status quo, which would also entail additional across the board cuts.

IDSA and HIVMA will continue to advocate for robust federal funding for domestic and global ID and HIV/AIDS programs in FY 2015 and beyond. With just weeks until the start of the new fiscal year, it is now critically important that Congress be urged to complete the FY 2015 appropriations process.  IDSA and HIVMA members are encouraged to take three minutes to email their members of Congress through the online Action Center.



< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Patient Care and Science
Sanford Guide Releases Mobile App for Lab Diagnosis of Infectious Diseases
NVAC Standards for Adult Immunization: What Do They Mean for the ID Specialist?
HCV Treatment Guidance Now Includes Information on Prioritizing Patients
Clinical Practice Management
New Resources on Co-management Agreements and Antimicrobial Stewardship Now Available
IDSA, HIVMA Appeal Medicaid Restrictions on Who Treats HCV
Policy and Advocacy
IDSA Convenes New National Stakeholder Group on Antimicrobial Resistance
Federal Funding Process Stalled Just Weeks Ahead of New Fiscal Year
Health Groups Share Federal Funding Experiences with Congress
Advocacy on New Antibacterial Drug Pathway Continues in the House
IDSA Submits Comments to FDA on Draft Guidance on Diagnostics
Global ID
Highlights from 20th International AIDS Conference
Education and Resources
Concerns Regarding Changes to MOC Requirements Shared with ABIM
IDSA Education and Research Foundation Launches New Website
Sign Up for OFID Table of Contents Alerts
You and Your Colleagues
In Memoriam: Gene H. Stollerman, MD, FIDSA (1920-2014)
IDSA Announces 2014 Fellows
Members on the Move
New Members
Top Stories
Presidentís Message: With the Spotlight on Drug Resistance, Itís Time for the ID Specialistís Role in Stewardship to Shine
IDSA Provides Ebola Resources for ID Clinicians
Countdown to IDWeek 2014
IDSA Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.